Education
About Us
Working with TipRanks
Follow Us
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Total Valuation
Tianda Pharmaceuticals Ltd. has a market cap or net worth of HK$273.06M. The enterprise value is HK$332.96M.
Market CapHK$273.06M
Enterprise ValueHK$332.96M
Share Statistics
Tianda Pharmaceuticals Ltd. has 2,150,041,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,150,041,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tianda Pharmaceuticals Ltd.’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -9.59%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-9.59%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee470.67K
Profits Per Employee-77.52K
Employee Count701
Asset Turnover0.43
Inventory Turnover4.42
Valuation Ratios
The current PE Ratio of Tianda Pharmaceuticals Ltd. is ―. Tianda Pharmaceuticals Ltd.’s PEG ratio is -0.04.
PE Ratio―
PS Ratio1.10
PB Ratio0.72
Price to Fair Value0.72
Price to FCF0.00
Price to Operating Cash Flow-7.90
PEG Ratio-0.04
Income Statement
In the last 12 months, Tianda Pharmaceuticals Ltd. had revenue of 329.94M and earned -61.37M in profits. Earnings per share was -0.03.
Revenue329.94M
Gross Profit152.02M
Operating Income-54.15M
Pretax Income-54.34M
Net Income-61.37M
EBITDA-49.49M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -26.10M and capital expenditures -16.97M, giving a free cash flow of -43.08M billion.
Operating Cash Flow-26.10M
Free Cash Flow-43.08M
Free Cash Flow per Share-0.02
Dividends & Yields
Tianda Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change-45.00%
50-Day Moving Average0.13
200-Day Moving Average0.15
Relative Strength Index (RSI)32.02
Average Volume (3m)84.94K
Important Dates
Tianda Pharmaceuticals Ltd. upcoming earnings date is Jul 1, 2026, TBA (Not Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateJul 1, 2026
Ex-Dividend Date―
Financial Position
Tianda Pharmaceuticals Ltd. as a current ratio of 0.86, with Debt / Equity ratio of 25.19%
Current Ratio0.86
Quick Ratio0.70
Debt to Market Cap0.34
Net Debt to EBITDA-0.84
Interest Coverage Ratio-11.16
Taxes
In the past 12 months, Tianda Pharmaceuticals Ltd. has paid 7.07M in taxes.
Income Tax7.07M
Effective Tax Rate-0.13
Enterprise Valuation
Tianda Pharmaceuticals Ltd. EV to EBITDA ratio is -8.19, with an EV/FCF ratio of 0.00.
EV to Sales1.23
EV to EBITDA-8.19
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Tianda Pharmaceuticals Ltd. has HK$103.77M in cash and marketable securities with HK$98.81M in debt, giving a net cash position of HK$4.95M billion.
Cash & Marketable SecuritiesHK$103.77M
Total DebtHK$98.81M
Net CashHK$4.95M
Net Cash Per Share<HK$0.01
Tangible Book Value Per ShareHK$0.16
Margins
Gross margin is 46.08%, with operating margin of -16.41%, and net profit margin of -18.60%.
Gross Margin46.08%
Operating Margin-16.41%
Pretax Margin-16.47%
Net Profit Margin-18.60%
EBITDA Margin-15.00%
EBIT Margin-15.00%
Analyst Forecast
The average price target for Tianda Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-19.28%
EPS Growth Forecast-42.27%